Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 90 Records) |
| Query Trace: Glioblastoma and TP53[original query] |
|---|
| Intronic TP53 Polymorphisms Are Associated with Increased ?133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers 2020 9 12 (9): . Eiholzer Ramona A, Mehta Sunali, Kazantseva Marina, Drummond Catherine J, McKinney Cushla, Young Katie, Slater David, Morten Brianna C, Avery-Kiejda Kelly A, Lasham Annette, Fleming Nicholas, Morrin Helen R, Reader Karen, Royds Janice A, Landmann Michael, Petrich Simone, Reddel Roger, Huschtscha Lily, Taha Ahmad, Hung Noelyn A, Slatter Tania L, Braithwaite Antony |
| Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neuro-oncology advances 2020 12 2 (1): vdaa142. Schulte Jessica D, Buerki Robin A, Lapointe Sarah, Molinaro Annette M, Zhang Yalan, Villanueva-Meyer Javier E, Perry Arie, Phillips Joanna J, Tihan Tarik, Bollen Andrew W, Pekmezci Melike, Butowski Nicholas, Oberheim Bush Nancy Ann, Taylor Jennie W, Chang Susan M, Theodosopoulos Philip, Aghi Manish K, Hervey-Jumper Shawn L, Berger Mitchel S, Solomon David A, Clarke Jennifer |
| Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma. Clinical neurology and neurosurgery 2020 11 200 106348. Pierscianek Daniela, Ahmadipour Yahya, Michel Anna, Rauschenbach Laurèl, Darkwah Oppong Marvin, Deuschl Cornelius, Kebir Sied, Wrede Karsten H, Glas Martin, Stuschke Martin, Sure Ulrich, Jabbarli Ramaz |
| Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma. Neoplasia (New York, N.Y.) 2020 11 22 (12): 800-808. Stasik Sebastian, Juratli Tareq A, Petzold Andreas, Richter Sven, Zolal Amir, Schackert Gabriele, Dahl Andreas, Krex Dietmar, Thiede Christi |
| Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population. PloS one 2020 11 15 (11): e0242793. Saadeh Fadi S, Morsi Rami Z, El-Kurdi Abdallah, Nemer Georges, Mahfouz Rami, Charafeddine Maya, Khoury Jessica, Najjar Marwan W, Khoueiry Pierre, Assi Hazem |
| TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-oncology advances 2020 11 2 (1): vdaa114. Kikuchi Zensho, Shibahara Ichiyo, Yamaki Tetsu, Yoshioka Ema, Shofuda Tomoko, Ohe Rintaro, Matsuda Ken-Ichiro, Saito Ryuta, Kanamori Masayuki, Kanemura Yonehiro, Kumabe Toshihiro, Tominaga Teiji, Sonoda Yukihi |
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
| A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing. Cellular oncology (Dordrecht) 2021 Jun . Fan Fan, Zhang Hao, Dai Ziyu, Zhang Yakun, Xia Zhiwei, Cao Hui, Yang Kui, Hu Shui, Guo Yong, Ding Fengqin, Cheng Quan, Zhang N |
| The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neuro-oncology advances 2021 6 3 (1): vdab050. Dono Antonio, Ramesh Arvind V, Wang Emily, Shah Mauli, Tandon Nitin, Ballester Leomar Y, Esquenazi Yosh |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study. Current oncology (Toronto, Ont.) 2021 Mar 28 (2): 1280-1293. Kalita Ondrej, Sporikova Zuzana, Hajduch Marian, Megova Houdova Magdalena, Slavkovsky Rastislav, Hrabalek Lumir, Halaj Matej, Klementova Yvona, Dolezel Martin, Drabek Jiri, Tuckova Lucie, Ehrmann Jiri, Vrbkova Jana, Trojanec Radek, Vaverka Mirosl |
| TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation. Open life sciences 2021 4 16 (1): 323-335. Yuan Hai-Yan, Lv Ya-Juan, Chen Yi, Li Dan, Li Xi, Qu Jian, Yan H |
| Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. The American journal of surgical pathology 2021 2 45 (8): 1082-1090. Eschbacher Kathryn L, Ida Cristiane M, Johnson Derek R, Alvi Mohammed A, Jenkins Sarah M, Ruff Michael W, Kerezoudis Panagiotis, Neth Bryan J, Pasion Romela M, Daniels David J, Kizilbash Sani H, Raghunathan Adit |
| IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
| BRAF Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAF . Frontiers in oncology 2021 1 10 531968. Da Rong, Wang Maode, Jiang Haitao, Wang Tuo, Wang W |
| Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma. Journal of neuro-oncology 2021 1 152 (1): 27-36. Bu Linghao, Hameed N U Farrukh, Luo Chen, Hong Pengjie, Zhou Xiaoyu, Wang Shengzhou, Wu Shu |
| Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma. Journal of neuro-oncology 2022 7 159 (2): 397-408. Suzuki Hayato, Ono Takahiro, Koyota Souichi, Takahashi Masataka, Sugai Tamotsu, Nanjo Hiroshi, Shimizu Hiroa |
| Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma. Neuro-oncology advances 2022 2 4 (1): vdac002. Yang Peter H, Tao Yu, Luo Jingqin, Paturu Mounica, Lu Hsiang-Chih, Ramkissoon Shakti, Heusel Jonathan W, Leuthardt Eric C, Chicoine Michael R, Dowling Joshua L, Dunn Gavin P, Duncavage Eric, Dahiya Sonika, Chattherjee Arindam R, Kim Albert |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
| Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-oncology 2022 12 . Alpen Karen, Vajdic Claire M, MacInnis Robert J, Milne Roger L, Koh Eng-Siew, Hovey Elizabeth, Harrup Rosemary, Bruinsma Fiona, Nguyen Tuong L, Li Shuai, Joseph David, Benke Geza, Dugué Pierre-Antoine, Southey Melissa C, Giles Graham G, Rosenthal Mark, Drummond Katharine J, Nowak Anna K, Hopper John L, Kapuscinski Miroslaw, Makalic En |
| Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study. Frontiers in oncology 2022 12 12 980059. Pan Rui, Wang Xiaotong, Fang Ru, Xia Qiuyuan, Wu Nan, Rao Q |
| Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors. Anticancer research 2022 12 42 (12): 6091-6098. Park Ji Hyun, Lee Hyun Seok, Choi Jin Woo, Lim So Dug, Koh Hyeon Kang, Cho Kyung Rae, Cho Joon, Koh Young-Cho, Yoon So You |
| Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
| Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. Journal of neuro-oncology 2022 1 156 (2): 353-363. Dono Antonio, Zhu Ping, Holmes Emma, Takayasu Takeshi, Zhu Jay-Jiguang, Blanco Angel I, Hsu Sigmund, Bhattacharjee Meenakshi B, Ballester Leomar Y, Kim Dong H, Esquenazi Yoshua, Tandon Nit |
| Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor. JCO precision oncology 2022 1 4 575-584. Yan Yuanqing, Takayasu Takeshi, Hines Gabriella, Dono Antonio, Hsu Sigmund H, Zhu Jay-Jiguang, Riascos-Castaneda Roy F, Kamali Arash, Bhattacharjee Meenakshi B, Blanco Angel I, Tandon Nitin, Kim Dong H, Ballester Leomar Y, Esquenazi And Yosh |
| Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis. Medical oncology (Northwood, London, England) 2023 4 40 (6): 161. Haofuzi Zhang, Mingdong Bao, Dan Liao, Zhuoyuan Zhang, Zhicheng Tian, Erwan Yang, Peng Luo, Xiaofan Jia |
| Polymorphisms in TPT1 Pathways in Pediatric Astrocytomas. ASN neuro 2023 1 15 17590914231153481. Morais de Castro Eduardo, Barbosa Leonardo Vinícius, Simoneti Fonseca Aline, Nagashima Seigo, Busatta Vaz de Paula Caroline, Zeni Rafaela, Panini do Carmo Letícia Arianne, Cavalli Luciane R, Bleggi Torres Luiz Fernando, Senff Ribeiro Andrea, de Noronha Lucia, Machado-Souza Cleb |
| Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: